Ali­gos cuts an­oth­er 10% of its work­force in repri­or­i­ti­za­tion for NASH and Covid pipelines

NASH and Covid-fo­cused Ali­gos Ther­a­peu­tics an­nounced that it is re­or­ga­niz­ing its pipeline and cut­ting around 10% of its staff to ex­tend its cash re­sources through the end of 2024.

In all, there’s been a 25% re­duc­tion in the over­all work­force at Ali­gos since the be­gin­ning of 2022, ac­cord­ing to the com­pa­ny. As of Sept. 30, 2022, Ali­gos had 89 full-time em­ploy­ees, in­clud­ing 72 em­ploy­ees in re­search and de­vel­op­ment, ac­cord­ing to SEC fil­ings.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.